Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
Russian and global pharmaceutical companies operating active substances’ production in Russia want to receive a premium of 40% of the value of the public procurements contracts signed with the Russian government, according to recent statements by Veronika Skvortsova, Russia’s Minister of Health, reports The Pharma Letter’s local correspondent. 4 October 2017
Biotechnology
Rare diseases had long been ignored in China until very recently. In May, China’s Food and Drug Administration (CFDA) drafted a policy to accelerate the approval process for innovative medical devices and drugs, including those for rare diseases, reports The Pharma Letter’s local correspondent Wang Fangqing. 29 September 2017
Pharmaceutical
Anglo-Swedish pharma major AstraZeneca may be the first multinational drugmaker operating in Russia that could sign a special investment contract with the Russian government, Denis Manturov, Russia’s Industry and Trade Minister has recently said. 28 September 2017
Generics
The Indian unit of beleaguered Netherlands-incorporated drugmaker Mylan has reached an agreement with Natsimbio, Russia’s leading producer of vaccines, on the supplies of its active substances for the production of anti-HIV drugs in Russia, according to the companies. 28 September 2017
Pharmaceutical
Cancer is on the rise in India. With 1 million people diagnosed with it every year, some 700,000 of them die, making it one of the leading causes of death in the country, reports The Pharma Letter’s India correspondent. 28 September 2017
Pharmaceutical
The Russian government has prepared a bill simplifying the introduction of new drugs into the domestic pharmaceutical market, a spokesman of state press-service has said recently, reports The Pharma Letter’s local correspondent. 25 September 2017
Pharmaceutical
Russian drugmaker Nanolek has reached an agreement with SK Chemicals on the establishment of production of vaccines at the facilities of the company’s Russian plant, which is located in Kirov region. 25 September 2017
Pharmaceutical
Mandatory immunization for children in India between nine months and 15 years of age against measles and rubella has not worked its charm, with India and Indonesia accounting for over 90% of unvaccinated children in Southeast Asia, according to the World Health Organization. Misconceptions and misinformation have turned out to be the main culprit, reports The Pharma Letter’s India correspondent. 11 September 2017
Pharmaceutical
Prices for drugs in Russia may increase by 15%-20% as soon as October of the current year, according to predictions of the Russian Ministry of Health reported by The Pharma Letter’s local correspondent. 5 September 2017
Biotechnology
Swiss pharma giant Roche will increase the level of localization in Russia through the establishment of full cycle of production of its Gaziva /Gazyvaro (obinutuzumab) antitumor drug, according to the company. 5 September 2017
Biosimilars
Expensive medicines that can generate billions of dollars in sales for drugmakers and the US Supreme Court's decision to speed access to copycat biologic drugs has found an echo in India, with the Indian biogenerics industry poised to exploit the opportunity similar to the generics potential, reports The Pharma Letter’s India correspondent. 30 August 2017
Generics
Russian drugmakers and foreign companies operating in the country have significantly increased the volume of pharmaceutical substances imports this year, a spokesman for Veronika Skvortsova, Russia’s Minister of Health, recently said, reports The Pharma Letter’s local correspondent. 21 August 2017
Pharmaceutical
A new leading drugmaker is to be established in Russia as a result of the recently announced merging of the pharmaceutical assets of Russian state corporation Rostec and local pharmaceutical producer Marathon Group. 9 August 2017
Generics
The Indian government is looking to review the existing drug price control measures in order to make medicines more affordable in the country, and at increasing the number of clinical trials taking place in the country, reports The Pharma Letter’s India correspondent. 5 August 2017
Pharmaceutical
Foreign pharma companies began a major push into the Japan market in the 1950s, albeit in the form of joint ventures (JVs) since ownership above 50% was not permitted, writes long-time Japanese industry watcher P Reed Maurer, president of International Alliances Limited, in his exclusive column for The Pharma Letter. 1 August 2017
Pharmaceutical
Drugs will be the subject for total labeling in the Russian pharmaceutical market according to a recent draft law, which was submitted for the consideration of the national Parliament (State Duma) by the Russian national government, reports The Pharma Letter’s local correspondent. 29 July 2017
Biosimilars
R-Pharm, one of Russia’s leading drugmakers, has signed an agreement with the USA’s clinical stage biotech firm Aspyrian Therapeutics on the transfer of the rights for the use of one of its investigational molecules by the US company during the development of anti-cancer drugs, reports The Pharma Letter’s local correspondent. 29 July 2017
Pharmaceutical
China has released a new list of 36 drugs, including 31 chemicals and biologics and five traditional Chinese medicines, covered by China’s national Medicare reimbursement scheme, reports The Pharma Letter’s local correspondent Wang Fangquing. 25 July 2017
Biotechnology
Stem cells are expected to dramatically improve the ability of drug companies to screen new drugs for side effects much earlier in the development process. Given that this is expected to significantly lower costs and shorten the time it takes to develop a new drug, India is looking to set forth new guidelines for stem cell research, reports The Pharma Letter’s India correspondent. 25 July 2017
Pharmaceutical
The launch of a new Russian-Nicaraguan vaccine production, which was recently established in the city of Managua with the aim of becoming one of the largest in Central and Latin America, will be postponed for the end of the current year, according to press-service of the Russian Ministry of Health. 19 July 2017
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Generics
Indian drugmaker Aurobindo Pharma has taken on the might of China in terms of Penicillin G pricing, and is doing so by leveraging a fully integrated production process at its new plant. Anticipating the price erosion of Penicillin G, the company has put up an integrated plant from scratch. 10 November 2024
Generics
Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new opportunities for India, especially in the pharmaceutical sector. 8 November 2024
Biotechnology
According to UNICEF's State of the World's Children 2023 report, in Latin America
and the Caribbean, 6.8 million children did not benefit from vaccination during the
time of the pandemic and in the following two years, progress has not been as
expected either. 7 November 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step towards consolidating and advancing the country's biotechnology initiative. 7 October 2024
Pharmaceutical
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Generics
The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall reduction of investment activities in the local pharmaceutical market, reports The Pharma Letter’s local correspondent. 30 September 2024
Pharmaceutical
Pharmaceutical laboratories, institutions, guilds and medical federations have taken on the task of designing programs to end health illiteracy in order to have informed, educated, knowledgeable and empowered communities where their health and wellbeing are concerned. 19 September 2024
Pharmaceutical
Oligonucleotide therapeutics are rapidly emerging as a promising class of drugs capable of addressing a variety of genetic and complex diseases by targeting RNA sequences.1 16 September 2024
Generics
The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, according to recent statements by Konstantin Panurovsky, legal director of AstraZeneca’s Russian subsidiary, reports The Pharma Letter’s local correspondent. 13 September 2024
Pharmaceutical
The Russian Ministry of Health wants to speed registration of drugs that are not localized in the Russian Federation at the time of the application submitted by domestic pharmaceutical companies, explaining such changes by "unpredictable geopolitical situation," reports The Pharma Letter’s local correspondent. 12 September 2024
Biotechnology
NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s 11 September 2024
Generics
A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 9 September 2024
Biotechnology
Targeted alpha therapy (TAT), or radioligand therapy, is a recent hot area that attracted big pharmas like Bristol Myers Squibb and Novartis. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Pharmaceutical
Scientists from the Russian Institute of Immunology of the Federal Medical and Biological Agency (FMBA) say they have created the world's first allergy vaccine. 30 August 2024
Generics
In a major crackdown, the Indian government has imposed an immediate ban on 156 fixed-dose combination (FDC) drugs, including commonly used antibiotics, pain relievers,and multivitamins. 27 August 2024
Pharmaceutical
Russia plans to create conditions for a significant increase of domestic production of anti-Rhesus immunoglobulin drugs after a sharp decrease of their imports to the local market this year, reports The Pharma Letter’s local correspondent. 22 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze